Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
A total of 3,888 pigs (337 × 1050, PIC, Hendersonville, TN; initially 6.0 ± 0.23 kg) were used in a 35-d study. At the time of placement, pens of pigs were weighed and allotted to one of three dietary treatments in a randomized complete block design with a blocking structure including sow farm origin, date of entry into the facility, and average pen body weight. A total of 144 pens were used with 72 double-sided 5-hole stainless steel fence line feeders, with one feeder serving as the experimental unit. For each feeder, 1 pen contained 27 gilts, and 1 pen contained 27 barrows. There were 24 replicates per dietary treatment. Diets were fed in three phases, and all contained 0.3 mg/kg added Se. A common phase 1 diet contained added Se from sodium selenite and was fed in pelleted form to all pigs from day 7 to approximately day 0. Three Se sources sodium selenite, Se yeast, and hydroxy-selenomethionine ( were used to formulate three experimental diets in meal form for phase 2 (days 0 to 14) and phase 3 (days 14 to 35). During the pre-treatment period (days 7 to 0), there was a tendency ( = 0.097) of a difference in average daily feed intake between treatments, although no significant pairwise differences were observed ( > 0.05). There were no other differences in growth performance between treatments from days 7 to 0. Clinical disease attributed to was observed within the trial between days 0 and 14, and water-soluble antimicrobial therapy was administered to all treatment groups for 7 d. From days 0 to 35, pigs fed OH-SeMet tended to have decreased average daily gain ( < 0.10) and increased ( < 0.05) serum and tissue selenium concentration compared to other treatments. There was marginally significant evidence of a source × day interaction ( = 0.027) for total antioxidant capacity where the numerical increase over time was less for the OH-SeMet than sodium selenite or selenium yeast treatments. There was no difference ( > 0.05) in antioxidant status as measured by serum glutathione peroxidase or thiobarbituric acid reactive substances assay between treatments. In summary, compared to sodium selenite and selenium yeast, OH-SeMet may have a greater bioavailability as indicated by increased serum and tissue selenium concentration; however, antioxidant status was similar between treatments and OH-SeMet tended to reduce growth performance compared with pigs fed sodium selenite.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224732 | PMC |
http://dx.doi.org/10.1093/tas/txad049 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!